Johnson & Johnson Total Liabilities
Johnson & Johnson (JNJ) had Total Liabilities of $116.09 billion as of 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-07-23
- 2026-06-28: Liabilities $116.09B.
- 2026-03-29: Liabilities $119.71B.
- 2025-12-28: Liabilities $117.67B.
- 2025-09-28: Liabilities $113.54B.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-28 | $116.09B 10-Q · filed 2026-07-23 | |
| 2026-03-29 | $119.71B 10-Q · filed 2026-04-22 | |
| 2025-12-28 | $117.67B 10-Q · filed 2026-07-23 | |
| 2025-09-28 | $113.54B 10-Q · filed 2025-10-22 | |
| 2025-06-29 | $114.92B 10-Q · filed 2025-07-24 | |
| 2025-03-30 | $115.56B 10-Q · filed 2025-04-23 | |
| 2024-12-29 | $108.61B 10-K · filed 2026-02-11 | |
| 2024-09-29 | $108.13B 10-Q · filed 2024-10-23 | |
| 2024-06-30 | $109.55B 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $101.95B 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $98.78B 10-K · filed 2025-02-13 | |
| 2023-10-01 | $94.83B 10-Q · filed 2023-10-27 | |
| 2023-07-02 | $115.28B 10-Q · filed 2023-07-31 | |
| 2023-04-02 | $125.10B 10-Q · filed 2023-04-28 | |
| 2023-01-01 | $110.57B 10-K · filed 2024-02-16 | |
| 2022-10-02 | $100.53B 10-Q · filed 2022-10-27 | |
| 2022-07-03 | $101.37B 10-Q · filed 2022-07-29 | |
| 2022-04-03 | $103.65B 10-Q · filed 2022-04-29 | |
| 2022-01-02 | $108.00B 10-K · filed 2023-02-16 | |
| 2021-10-03 | $108.96B 10-Q · filed 2021-10-29 | |
| 2021-07-04 | $106.86B 10-Q · filed 2021-07-29 | |
| 2021-04-04 | $106.72B 10-Q · filed 2021-04-30 | |
| 2021-01-03 | $111.62B 10-K · filed 2022-02-17 | |
| 2020-09-27 | $106.22B 10-Q · filed 2020-10-23 | |
| 2020-06-28 | $95.40B 10-Q · filed 2020-07-24 | |
| 2020-03-29 | $93.72B 10-Q · filed 2020-04-29 | |
| 2019-12-29 | $98.26B 10-K · filed 2021-02-22 | |
| 2019-09-29 | $97.31B 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $94.33B 10-Q · filed 2019-07-29 | |
| 2019-03-31 | $91.07B 10-Q · filed 2019-05-01 | |
| 2018-12-30 | $93.20B 10-K · filed 2020-02-18 | |
| 2018-09-30 | $91.08B 10-Q · filed 2018-10-31 | |
| 2018-07-01 | $92.48B 10-Q · filed 2018-08-02 | |
| 2018-04-01 | $93.37B 10-Q · filed 2018-05-01 | |
| 2017-12-31 | $97.14B 10-K · filed 2019-02-20 | |
| 2017-10-01 | $81.68B 10-Q · filed 2017-11-02 | |
| 2017-07-02 | $80.89B 10-Q · filed 2017-08-03 | |
| 2017-04-02 | $74.58B 10-Q · filed 2017-05-08 | |
| 2017-01-01 | $70.79B 10-K · filed 2018-02-21 | |
| 2016-10-02 | $67.60B 10-Q · filed 2016-11-04 | |
| 2016-07-03 | $67.34B 10-Q · filed 2016-08-04 | |
| 2016-04-03 | $63.58B 10-Q · filed 2016-05-10 | |
| 2016-01-03 | $62.26B 10-K · filed 2017-02-27 | |
| 2015-09-27 | $61.71B 10-Q · filed 2015-10-30 | |
| 2015-06-28 | $60.91B 10-Q · filed 2015-07-31 | |
| 2015-03-29 | $60.71B 10-Q · filed 2015-05-01 | |
| 2014-12-28 | $60.61B 10-K · filed 2016-02-24 | $61.37B 10-K · filed 2015-02-24 |
| 2014-09-28 | $55.51B 10-Q · filed 2014-10-30 | |
| 2014-06-29 | $57.15B 10-Q · filed 2014-08-01 | |
| 2014-03-30 | $56.75B 10-Q · filed 2014-05-02 | |
| 2013-12-29 | $58.63B 10-K · filed 2015-02-24 | |
| 2013-09-29 | $57.13B 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $54.66B 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $54.68B 10-Q · filed 2013-05-03 | |
| 2012-12-30 | $56.52B 10-K · filed 2014-02-21 | |
| 2012-09-30 | $55.19B 10-Q · filed 2012-11-09 | |
| 2012-07-01 | $55.32B 10-Q · filed 2012-08-02 | |
| 2012-04-01 | $54.83B 10-Q · filed 2012-05-07 | |
| 2012-01-01 | $56.56B 10-K · filed 2013-02-22 | |
| 2011-10-02 | $50.29B 10-Q · filed 2011-11-08 | |
| 2011-07-03 | $49.98B 10-Q · filed 2011-08-09 | |
| 2011-04-03 | $48.29B 10-Q · filed 2011-05-10 | |
| 2011-01-02 | $46.33B 10-K · filed 2012-02-23 | |
| 2010-10-03 | $40.96B 10-Q · filed 2010-11-10 | |
| 2010-07-04 | $39.45B 10-Q · filed 2010-08-11 | |
| 2010-04-04 | $40.53B 10-Q · filed 2010-05-10 | |
| 2010-01-03 | $44.09B 10-K · filed 2011-02-25 | |
| 2009-09-27 | $41.17B 10-Q · filed 2009-11-04 | |
| 2009-06-28 | $41.19B 10-Q · filed 2009-08-04 | |
| 2008-12-28 | $42.40B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |